Live Cell Therapy updates

Live Cell Therapy news coverage of developments with the latest updates. Stay on top of latest Cell Therapy news stories and find out what just happened, what is going on with Cell Therapy. The latest real-time news updates and headlines on Cell Therapy
Cellular Senescence Trumps Mutations in Aging Evidence
Blind Retina Noise May Hinder Sight Restoration
Stress Hormone Timing Creates Different Kind Of Obesity
New Method Tested Against Bacterial Toxin In Brain
Shingles Pain Lingers: Scientists Uncover Causes
Research: Cancer Protein Binds Chromosome Unexpectedly
Few Older Americans Seek Counseling: Potential Benefits
Exosome Study Uncovers Shingles Pain Relief Pathways
Landmark Study Redefines Rare Disorders
Can Ink Stay In Skin?
Ecosystem Study in Earth's Fastest-Warming Region
Hanbat Univ. Unveils Separator To Boost Lithium Battery
Blood Biomarker Tracks Lecanemab Response in Alzheimer's
Finding Future In Pharmacy
DNA Organization Key to Tissue Regeneration, Study Finds
Research Probes Epilepsy Drug Safety With Anticoagulants
Probing Origins of Childhood Cancer Tumors
K-Beauty Hits Coles: Supermarket Skincare Glows Up
Magnetic Pulses Reprogram Immune Cells to Combat Cancer
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
MIT Spinout Transforms Plastic Waste into Building Materials
KAIST Team Reveals Neuron RNA Delivery Mechanism
Amivantamab-Chemo Yields Best Survival in EGFR NSCLC
Zidesamtinib Shows 93% Response in ROS1-positive NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
KAIST, KIOM Unveil Wearable Microneedle For Pain Relief
PBS Adds First Biologic for Uncontrolled COPD
KAIST, KIOM Create Wearable Pain-Relief Device
Bungendore Bowls Against Prostate Cancer for Mate
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Ivonescimab Boosts Survival in PD-L1+ Advanced NSCLC
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
Pumitamig Plus Elfetabart Shows Promise in Lung Cancer
Tarlatamab Dosing Shows Promise in Small Cell Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Phase 1 Backs Phase 3 Dose for Lung Cancer Drug
Atezolizumab Combo Doubles Event-Free Survival in NSCLC
Subcutaneous Tarlatamab Safe, Effective in SCLC Trial
SERENA-4 Trial: Etcamah, Palbociclib in ER+ Breast Cancer
CU Anschutz Advances Precision Medicine for Rare Cancers
Building Better CAR T-Cells For Cancer Treatment
Bone Marrow-on-a-Chip Model Studies Immune Cells
Smart Nanoparticles Boost Immune Attack on Tumors
Brain Info Processing: New Findings Unveiled